3 Under-$10 Canadian Stocks to Buy Right Now

These three unde-$10 Candian stocks offer high-growth prospects and deliver superior returns over the next three years.

| More on:
investment research

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

Investing in equity markets does not always require huge capital upfront. Even with a small but regular investment, one can create significant wealth over the long term. So if you are ready to invest, here are three Canadian stocks that you can buy under $10 to earn superior returns over the next three years.


B2Gold (TSX:BTO)(NYSEMKT:BTG) is a gold mining company with its mines located in Mali, Namibia, and the Philippines. The company had reported a solid first-quarter performance last week, with its adjusted EPS of $0.09, beating analysts’ expectations of $0.07. Meanwhile, its revenue of $362.3 million fell marginally short of analysts’ expectations.

Year over year, B2Gold’s revenue fell 4.7%. The decline in gold ounces sold during the quarter dragged the company’s top-line down. However, higher average realized gold prices offset some of the declines. Amid the planned waste stripping and lower mined ore grades, the company’s production declined during the quarter.

However, the company’s management expects its production to improve in the second half of this year, as the mining reaches the higher-grade zones. For this year, the company’s management expects its gold production to come in the range of 970,000 – 1,030,000 ounces. Over the last 30 days, gold prices have increased by 5.8%. Meanwhile, the uptrend could continue given the volatility in the broader equity markets, thereby benefiting gold-mining companies.

Aurora Cannabis

Amid the weakness in the cannabis sector, Aurora Cannabis (TSX:ACB)(NYSE:ACB) has lost close to 60% of its stock value from its February highs. The steep correction offers an excellent buying opportunity, given the expanding cannabis market amid increased legalization and the company’s growth initiatives.

Aurora Cannabis has captured a significant market share in the Canadian and international medical cannabis markets. Currently, it earns revenue from over 13 countries. The company focuses on increasing its market share and also expand its footprint into newer markets. Management also hopes that some of these medical channels would migrate to consumer channels in the coming years.

Its CBD brand, Reliva, has received a positive response from U.S. customers. The company is working on expanding the availability of the product across the United States. With its cash and cash equivalents standing at $565 million, Aurora Cannabis is well positioned to fund its growth initiatives.

WELL Health Technologies

Yesterday, WELL Health Technologies (TSX:WELL) had reported an impressive first-quarter performance, with its top-line increasing by 150% to $25.6 million. Its acquisitions over the last four quarters and organic growth in its various business units drove its revenue. It also posted positive adjusted EBITDA for the second quarter in a row, with its Canadian operations posting strong performance during the quarter.

Meanwhile, WELL Health acquired ExecHealth, IntraHealth and CRH Medical in the second quarter. With these acquisitions, the company’s annualized revenue run-rate is approaching $300 million per year. It also strengthened its billing and back-office segment by acquiring a 51% stake in Doctors Services Group. Further, the company has launched Health Records on iPhone, which would allow iPhone users to retrieve health records from participating clinics. So, the company’s growth prospects look healthy.

Meanwhile, amid the recent sell-off in tech stocks, WELL Health is trading at a 26.5% discount from its February highs. I believe investors should utilize the correction to accumulate the stock to earn superior returns.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Rajiv Nanjapla has no position in any of the stocks mentioned.

More on Tech Stocks

Arrow descending on a graph
Tech Stocks

2 Industries That Saw the Worst Decline Last Month

The TSX has been declining at a sharp angle since the beginning of June. And two industries (crypto and cannabis)…

Read more »

Dividend Stocks

TFSA Investors: Turn $1,000 Into $10,000 in 10 Years

10-fold growth within a decade is rare but not unheard of. You can capture this growth either by predicting a…

Read more »

Growth from coins
Tech Stocks

Got $1,000? Buy These 3 Under-$20 Growth Stocks to Earn Higher Returns

These under-$20 growth stocks can deliver solid returns in the long run.

Read more »

Shopping card with boxes labelled REITs, ETFs, Bonds, Stocks
Tech Stocks

TFSA Investors: 3 TSX Stocks You’ll Regret Not Buying on the Dip

Among wide range of investments allowed in a TFSA, now is the time to invest in stocks.

Read more »

Tired or stressed businessman sitting on the walkway in panic digital stock market financial background
Tech Stocks

2 Stocks That Lost Over 50% in 2022

The recovery of the TSX’s tech superstar and a promising high-growth stock that lost more than 50% in 2022 is…

Read more »

Man holding magnifying glass over a document
Tech Stocks

Why BlackBerry Stock Looks Way Too Undervalued After Q1 Earnings

BB stock hasn’t seen any appreciation lately, despite its continued progress on the IVY platform and early signs of the…

Read more »

A stock price graph showing declines
Tech Stocks

BlackBerry Q1 Earnings: The Declining Revenue Streak Continues!

Will BB stock break below $6?

Read more »

A bull outlined against a field
Tech Stocks

After the Recent Fall, it’s Time to Turn Bullish on 2 TSX Growth Stocks

With the kind of lows these TSX stocks have seen, the negatives appear to be priced in.

Read more »